Coordinate expression of virulence factors in pathogenic Escherichia coli
Coordinate expression of virulence factors in pathogenic Escherichia coli
批准号:
nhmrc : 301163
负责人:
Prof Mark Schembri
金额:
$15.95万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Escherichia coli is a versatile pathogen capable of causing a range of disease types including diarrhoea, dysentery, haemolytic uremic syndrome, bladder and kidney infections, septicaemia, pneumoniae and meningitis. Infections due to pathogenic E. coli may be limited to mucosal surfaces or can disseminate throughout the body. Amongst the different classes of pathogenic E. coli, diarrheagenic strains (namely enterotoxigenic and enteroinvasive E. coli) are responsible for the death of an estimated one million humans per year, mainly in third world countries. The majority (80%) of urinary tract infections (UTIs) in humans are caused by E. coli and in Australia alone there are about 250,000 cases per year. It is estimated that one in four women and one in twenty men will develop a urinary tract infection in their lifetime. Pathogenic E. coli strains are normally equipped with multiple virulence factors and there is mounting evidence that the expression of such factors is finely orchestrated by mutual regulatory cross-talk. For example, expression of flagella (which provide motility) and adhesins (which provide attachment) are fundamentally counteracting phenotypes, yet the molecular and genetic mechanisms that coordinate their expression are unknown. I plan to examine inter-system cross-regulation of bacterial surface structures (namely adhesins, autoaggregaters, capsules and flagella). The aim is to understand on the molecular level how microorganisms orchestrate expression of virulence factors and will have consequences for our understanding of microbial pathogenicity. The strategy outlined may lead to new routes for strain attenuation and perhaps a method for vaccine strain construction. The research will be performed in collaboration with international high profile partners.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Untangling the matrix of bacterial biofilms
-
批准号:DP230101930
-
项目类别:Discovery Projects
-
资助金额:$33.22万
-
财政年份:2023
-
负责人:Prof Mark Schembri
-
依托单位:
The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
-
批准号:nhmrc : GNT1144967
-
项目类别:Project Grants
-
资助金额:$78.44万
-
财政年份:2018
-
负责人:Prof Mark Schembri
-
依托单位:
The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
-
批准号:nhmrc : 1144967
-
项目类别:Project Grants
-
资助金额:$53.04万
-
财政年份:2018
-
负责人:Prof Mark Schembri
-
依托单位:
Membrane-active antibiotics against multi-drug resistant Gram negative bacteria
-
批准号:nhmrc : 1106590
-
项目类别:Project Grants
-
资助金额:$64.88万
-
财政年份:2016
-
负责人:Prof Mark Schembri
-
依托单位:
Halting the spread multidrug resistant uropathogenic E. coli
-
批准号:nhmrc : GNT1106930
-
项目类别:Research Fellowships
-
资助金额:$68.8万
-
财政年份:2016
-
负责人:Prof Mark Schembri
-
依托单位:
Halting the spread multidrug resistant uropathogenic E. coli
-
批准号:nhmrc : 1106930
-
项目类别:Research Fellowships
-
资助金额:$47.43万
-
财政年份:2016
-
负责人:Prof Mark Schembri
-
依托单位:
Membrane-active antibiotics against multi-drug resistant Gram negative bacteria
-
批准号:nhmrc : GNT1106590
-
项目类别:Project Grants
-
资助金额:$94.23万
-
财政年份:2016
-
负责人:Prof Mark Schembri
-
依托单位:
The current multidrug resistant Escherichia coli pandemic: exploring novel therapies against the predominant culprit E. coli ST131.
-
批准号:nhmrc : 1069370
-
项目类别:Project Grants
-
资助金额:$34.16万
-
财政年份:2014
-
负责人:Prof Mark Schembri
-
依托单位:
Role of autotransporter proteins in uropathogenic E. coli infections
-
批准号:nhmrc : 1042651
-
项目类别:Project Grants
-
资助金额:$40.75万
-
财政年份:2013
-
负责人:Prof Mark Schembri
-
依托单位:
How bacteria cause disease in the urinary tract
-
批准号:FT100100662
-
项目类别:ARC Future Fellowships
-
资助金额:$57.36万
-
财政年份:2011
-
负责人:Prof Mark Schembri
-
依托单位:
Autotransporter proteins of enterohemorrhagic Escherichia coli O157:H7
-
批准号:DP1097032
-
项目类别:Discovery Projects
-
资助金额:$20.9万
-
财政年份:2010
-
负责人:Prof Mark Schembri
-
依托单位:
Adhesins of uropathogenic Escherichia coli
-
批准号:nhmrc : 631654
-
项目类别:NHMRC Project Grants
-
资助金额:$27.05万
-
财政年份:2010
-
负责人:Prof Mark Schembri
-
依托单位:
Disulfide catalysis and protein folding in bacterial virulence
-
批准号:DP1096395
-
项目类别:Discovery Projects
-
资助金额:$20.9万
-
财政年份:2010
-
负责人:Prof Mark Schembri
-
依托单位:
Molecular basis of asymptomatic colonization of the human urinary tract
-
批准号:nhmrc : 569676
-
项目类别:NHMRC Project Grants
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Prof Mark Schembri
-
依托单位:
Urinary tract E. coli: the good guys versus the bad guys
-
批准号:nhmrc : 401714
-
项目类别:NHMRC Project Grants
-
资助金额:$19.75万
-
财政年份:2007
-
负责人:Prof Mark Schembri
-
依托单位:
Safety in numbers: Bacterial aggregation and adaptation to oxidative stress
-
批准号:DP0666852
-
项目类别:Discovery Projects
-
资助金额:$14.18万
-
财政年份:2006
-
负责人:Prof Mark Schembri
-
依托单位:
Autotransporter proteins of Escherichia coli
-
批准号:DP0557615
-
项目类别:Discovery Projects
-
资助金额:$15.96万
-
财政年份:2005
-
负责人:Prof Mark Schembri
-
依托单位:
国内基金
海外基金
登录
查看更多内容
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
低氧相关lncRNA UTGF调控TGF-β信号传导及转移的作用及机制
-
批准号:32100573
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:伍梦芝
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位: